Sigma-Aldrich submits CRISPR petition at USPTO

Merck KGaA-owned Sigma-Aldrich has petitioned the US Patent and Trademark Office (USPTO) to open an interference proceeding between its own pending CRISPR-Cas9 patents and patents awarded to the University of California, Berkeley (UC Berkeley).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Merck KGaA secures second US CRISPR patent

9 April 2020 Millipore Sigma, the US life sciences business of Merck KGaA, has secured a patent for its CRISPR-chrom technology, bringing its total number of CRISPR-related patents to 23.

Asia

Merck KGaA secures CRISPR patents in Japan and Singapore

27 November 2019 The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.

Europe

Merck and Evotec strike CRISPR licensing deal

14 November 2019 Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.

More on this story

Americas

Merck KGaA secures second US CRISPR patent

9 April 2020 Millipore Sigma, the US life sciences business of Merck KGaA, has secured a patent for its CRISPR-chrom technology, bringing its total number of CRISPR-related patents to 23.

Asia

Merck KGaA secures CRISPR patents in Japan and Singapore

27 November 2019 The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.

Europe

Merck and Evotec strike CRISPR licensing deal

14 November 2019 Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.

More on this story

Americas

Merck KGaA secures second US CRISPR patent

9 April 2020 Millipore Sigma, the US life sciences business of Merck KGaA, has secured a patent for its CRISPR-chrom technology, bringing its total number of CRISPR-related patents to 23.

Asia

Merck KGaA secures CRISPR patents in Japan and Singapore

27 November 2019 The Japan Patent Office and the Intellectual Property Office of Singapore have each granted Merck KGaA a patent covering the use of paired CRISPR nickases.

Europe

Merck and Evotec strike CRISPR licensing deal

14 November 2019 Merck has agreed to license its CRISPR gene-editing technology to German biotech company Evotec.